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Haemophilus influenzae type b is the most common cause of bacterial meningitis 
in  childhood, and  despite the availability of potent antibiotics,  this  pathogen 
continues to produce significant morbidity and mortality (1). The polyribosylri- 
bitol phosphate (PRP) 1 capsule of H. influenzae type b  has been shown to be an 
important virulence factor in  invasive haemophilus infection (2,  3),  and there 
have been major efforts in recent years to develop an effective vaccine incorpo- 
rating PRP antigen (4, 5). Although the pathogenesis and prevention of systemic 
haemophilus infection have been investigated intensively, mucosal colonization 
and  penetration  have  received  considerably  less  attention  and  are  not  well 
understood. As a result, immunization strategies directed against events preced- 
ing bloodstream invasion have not been actively pursued. 
Many gram-negative bacteria possess filamentous surface appendages known 
as  pili  or  fimbriae  (6,  7).  These  protein  structures  may  have  a  number  of 
important functions in bacterial pathogenicity (8).  One of the best documented 
roles for pili  is  mediation of bacterial  adherence to  epithelial  cell surfaces, a 
logical first step  in  the pathogenesis of infection (9).  Purified pili  have been 
shown to be good immunogens, and studies in experimental animal models, as 
well as in natural hosts, have shown them to be potentially important vaccine 
components (10-12). 
Recently (13-16), clinical isolates of H. influenzae have been shown to express 
pili.  Furthermore, only the piliated phase of H.  influenzae  adheres strongly to 
isolated human oropharyngeal cells (13,  14).  In this study, we report a  rapid, 
straightforward purification procedure for H.  influenzae  pili, along with studies 
on their chemical, physical, and serological properties. 
Abbreviations used in this paper:  BH1,  brain heart infusion; ELISA, enzyme-linked  immunosor- 
bent assay; EM, electron microscopy;  MS, mannose-sensitive;  PRP, polyribosylribitol  phosphate; Pth, 
phenythiohydantoin;  SAS, saturated ammonium  sulfate; SDS-PAGE, sodium dodecyl  sulfate-poly- 
acrylamide  gel electrophoresis. 
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Methods 
Bacterial Strains.  Seven H. influenzae type b strains and one H. influenzae nontypable 
strain were used in this study. Strains A02 and A14 have been described previously (14). 
Strain A46 was provided by Dr. S. Kaplan (Baylor College of Medicine, Houston, TX) 
and strain A52 was provided by Dr. D. Granoff (St. Louis Children's Hospital, St. Louis, 
MO). The remaining type b strains (A 16, A01, A43) were supplied by the Bacteriology 
Laboratory, Children's Hospital, Boston, MA. All of the type b strains were clinical isolates 
from throat, blood, or cerebrospinal fluid cultures. Strain A03, the nontypable strain, was 
provided by Dr. J. Gilsdorf, (University of Minnesota Medical School, Minneapolis, MN). 
Four  E.  coli  strains  were  used  in  this  study.  E.  coli  strain  C94  (07:KI:H-)  is  a 
cerebrospinal fluid isolate from a human neonate with meningitis and has been described 
previously (17). E.  coli  strain  H10407 (078:K80:Hll) is an isolate from an adult with 
diarrhea (18); it was obtained from Dr. Edgar Boedeker (Walter Reed Army Institute of 
Research, Washington, D.C.).  Both strains produce non-mannose-sensitive and mannose- 
sensitive (MS) pili. 
E.  coil strain 3669 (02, K nontypable), a urine isolate from a girl with acute pyelone- 
phritis, was kindly provided by Dr. C. Svanborg-Eden (University of Goteborg, Sweden). 
E. coli strain J96 (04, K6) is also a pyeionephritis isolate (19). When grown for 18 h on 
solid medium at 37 °C, these strains exhibit only P-binding specificity (20). 
Bacterial Growth and Pilus Purification.  All H, influenzae strains were grown on brain 
heart infusion (BHI) agar (Difco Laboratories, Inc., Detroit, MI) supplemented with 10 
#g/ml heroin, 10 #g/ml L-histidine, and 2 #g/ml ~-nicotinamide adenine dinucleotide (all 
from Sigma Chemical Co., St. Louis, MO), at 37°C in 5% CO2/95% air. 
For pilus purification, each H. influenzae isolate was enriched for the piliated phase by 
selective absorption to human type O red blood cells as described previously (14). Piliated 
bacteria were then cultured onto fresh BHI agar and the overnight growth from each 
plate was suspended in 2% casamino acids (Difco Laboratories, Inc.,) and used to inoculate 
two 33 ×  223 cm Pyrex baking dishes containing BHI agar. After incubation for 18 h, 
the growth was harvested by scraping the agar surface with a glass rod, suspending the 
organism in 15 ml of buffer, and then detaching and purifying the pili as described below 
(See Results). 
E. coli strains C94 and H10407 were selectively grown for the piliated phases, and MS 
pili were purified as described previously (17). E.  coli P pili were prepared from recom- 
binant strain HU849, a construct derived from J96 DNA that expresses P pili,  but not 
MS pili, and mediates P-specific hemagglutination (19).  Organisms were grown on tryp- 
ticase soy agar (Difco Laboratories, Inc.) for 24 h at 37 °C, harvested into ice-cold 0.005 
M Tris-HCl buffer, pH 8.3, (T buffer), and homogenized (4,000 rpm) for 30 min at 4°C 
in a  Sorvall Omnimixer (Sorvali Biomedical Div.  DuPont Co.,  Wilmington,  DE).  The 
sheared bacteria were then removed by centrifugation at  12,000 g  for 30  min.  Pilus 
filaments were precipitated in 0.05 M Tris-HCI buffer, pH 7.0, containing 0.15 M NaCi, 
by the addition of MgC12 to 0.1  M (TSM buffer), collected by centrifugation at 12,000 g 
for 45 min, and the pellet dissolved in T  buffer. Insoluble contaminants were removed 
by centrifugation at 12,000 g for 60 min and the pili precipitated from the supernatant 
in TSM buffer. After six successive cycles of solubilization and crystalization by exposure 
to T and TSM buffer, respectively, the pili were  judged to be pure by electron microscopy, 
sodium  dodecyl  sulfate-polyacrylamide gel  electrophoresis (SDS-PAGE),  and  amino- 
terminal amino acid sequence analysis (20). 
Pilus Solution  Solubility Studies.  The solubility of intact H.  influenzae  pilus rods was 
determined as a function of  percent saturated ammonium sulfate (SAS) and pH by solution 
optical density measurements as previously described (21).  A wavelength of 400 nm was 
selected to obtain optimal light scattering from pilus aggregation without the effects of 
specific protein absorption. For SAS aggregation studies, pilus suspensions were adjusted 
to constant molarity Tris-HC! (0.05 M, pH 9.5) (Sigma Chemical Co.). For pH solubility 
studies, the pili were dialyzed overnight at 4°C against a  constant ionic strength (# = 
0.15) sodium phosphate buffer (Mallinckrodt Inc., St.  Louis, MO) at pH values ranging 
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Polyacrylamide Gel Electrophoresis.  SDS-PAGE was performed in 1-mm-thick slab gels 
(gel concentration, 15%) by the method of Laemmli (22). Standard proteins were bovine 
serum albumin, egg albumin, typsinogen, 3-1actoglobulin, and lysozyme (Sigma Chemical 
Co.). 
Gels were stained with 0.25% Coomassie Brilliant Blue solution (Schwarz/Mann Div., 
Becton, Dickinson & Co., Orangeburg, NY) in methanol/acetic acid/distilled Water (5:5:1). 
To obtain an estimate of the percentage of total Coomassie Blue-stainable protein present 
in each gel band, we scanned gels with a Quick Scan densitometer (Helena Laboratories, 
Beaumont, TX). 
Identification of the Major Protein Product in Pilus Preparation.  The major protein band 
in SDS-PAGE profiles was identified as pili by immunolabeling pilus rods with antibody 
produced against this major band.  A  total of 1.5  mg of protein from a  purified pilus 
preparation was electrophoresed in a  15% SDS-polyacrylamide gel under standard Lae- 
mmli conditions as described above. After electrophoresis, a portion of the gel was stained 
with Coomassie Blue as described above, and the remainder of the gel was placed in a 0.2 
M KCI (Mallinckrodt Inc.) solution at 4°C. All Coomassie Blue-staining protein bands 
could also be identified as discrete white precipitates in the fresh unstained portion of the 
gel within 5 rain of soaking in the cold KCI solution. The major (25,000 reel wt) band 
was cut from the unstained gel and emulsified in 0.001 M phosphate-buffered saline. The 
band preparation was then mixed 1:1 with Freund's incomplete adjuvant (Difco Labora- 
tories, Inc.) and used to immunize rabbits by subcutaneous injection as described below. 
Each rabbit received three injections, each containing ~0.5 mg of protein. After the final 
injection, antisera were titered by enzyme-linked immunosorbent assay (ELISA) and used 
for pilus immunoelectron microscopy as described below. 
Amino  Acid  Analysis.  The  amino  acid  composition  of pure  H.  influenzae  pili  was 
determined by hydrolysis in 4 N methane-sulfonic acid (23) in evacuated, sealed tubes at 
115°C for 22, 48, and  108 h. The values for serine and threonine were corrected for 
destruction during hydrolysis by extrapolation to 0 time. The values for leucine, isoleucine, 
and valine were corrected for slow  hydrolysis of the peptide bond by extrapolation to 
infinite time. Half-cysteine and methionine were determined as cysteic acid and methio- 
nine sulfone, respectively, after performic acid oxidation of the methane-sulfonic acid 
hydrolysate. 
Sequence Analysis.  Automated Edman degradation was  performed with a  Beckman 
890C sequencer (Beckman Instruments, Inc., Pale Alto, CA),  using a modified Quadral 
program (Beckman Instruments) in combination with polybrene. Thiazolinone derivatives 
of amino acids were converted to phenythiohydantoin (Pth) derivatives with aqueous 1.0 
N HCI at 80°C for 10 rain. Pth amino acids were identified by high performance liquid 
chromatography (HPLC) with a  Hewlett Packard  1084B HPLC (Hewlett-Packard Co., 
Pale Alto, CA), using DuPont Zorbex ODS columns. They were then confirmed by gas 
chromatography and/or thin-layer chromatography. 
Electron Microscopy.  Bacterial suspensions and purified pilus preparations were rou- 
tinely prepared for electron microscopy (EM) by the agar filtration, negative staining 
method (24) as modified by To (25). This method sandwiches all particulate material in a 
suspension between two coiloidin membranes, thus permitting accurate evaluations of the 
degree of piliation in a bacterial culture, or the presence of particulate impurities in a 
pilus  preparation,  without  the  artifact of selective absorption  encountered by simple 
adhesion methods. 
To measure pilus diameters and lengths, EM specimens were prepared by adhesion/ 
negative staining using tobacco mosaic virus stacked double discs as internal size markers, 
as previously described (21).  In all cases,  pilus preparations were in  0.05  M  Tris-HCl 
(Sigma Chemical Co.), pH 9.5. All EM specimens were examined at 60-80 kV in a JEOL 
100S electron microscope (JEOL USA, Cranford, NJ). 
Serological Studies.  Antisera were prepared against purified pili by subcutaneous im- 
munizations of young virgin white female New  Zealand rabbits  (Pine Acre  Rabbitry, 
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mixed with an equal volume of Freund's incomplete adjuvant, were given, each 1-2 ml 
VOl. 
Preimmune sera and antisera were titered against purified pilus preparations using an 
ELISA. Purified pili  (0.1 mg/ml in  50  mM NaCO3,  pH  9.5)  were added to polyvinyl 
chloride microtiter plates (Dynatech Laboratories, Alexandria, VA) and incubated at 4 °C 
overnight. The wells were then blocked with 1% gelatin in 50 mM NaCOs and incubated 
at  4°C  overnight.  Goat anti-rabbit  IgG  conjugated to  horseradish  peroxidase  (Miles 
Laboratories, Elkhart, IN) was added for 3 h at 37°C and then the substrate O-phenyl- 
enediamine was placed in each well. The reaction with substrate was stopped after 20 min 
with 3.5 M HCi. Optical density was then determined at 490 nm on an enzyme immu- 
noassay (EIA) reader (Bio-Tek Instruments, Inc., Burlington, VT). 
Cross-reactivities between antiserum against purified A02  pili  and  heterologous H. 
influenzae  pili were also examined by whole-cell agglutination of purified bacteria. 50 ~1 
of an antiserum dilution was placed on a glass microscope slide, and a loopfui of piliated 
bacteria was vigorously mixed into the drop. The bacteria-antiserum mixture was gently 
swirled at 24 °C on a Lab-line  Junior Orbital Shaker (Lab-Line Instruments, Inc., Melrose 
Park,  IL) for  10  min, and  examined in  a  dark-field microscope at  10×  and  20×  to 
determine agglutination. Twofold dilutions of antiserum were  used to determine the 
agglutination titer. Antiserum produced against a native A02 pilus preparation showing 
very high protein  purity, as well as antiserum produced against the major A02  pilus 
protein band cut from an SDS-polyacrylamide gel were used; the latter minimized the 
possible presence of antibody against n0npilus bacterial antigens. Preimmune sera and an 
isogenic nonpiliated subpopulation of each strain we~'e used for controls except as noted 
in the text. 
Cross-reactivity was also tested between H. influenzae  pili and E. coli MS and P pili by 
ELISA, whole piliated cell agglutination and immunoelectron microscopy (21). For these 
studies, antisera were produced against purified pili from E.  coli strains C94, H10407, 
and HU849. 
Results 
Pilus Purification 
An initial crude pilus preparation was obtained from H. influenzae strain A02 
by harvesting bacteria  with  0.1  M  Tris-HC1,  pH  8.5,  blending with a  Sorvall 
Omnimixer (¾ maximal setting), and separating detached pili from bacteria by 
centrifugation at 8,000 g for 20 min at 4°C. Saturated ammonium sulfate (SAS) 
was  then  added  to  aliquots  of the  resulting  supernatant  at  24°C  to  achieve 
solutions ranging from 5  to 45%  saturation.  The resulting solutions were ex- 
amined by dark-field microscopy for pilus aggregates, which were evident at SAS 
concentrations of 35%  saturation.  The aliquots were pooled, adjusted to 45% 
SAS, and centrifuged at 8,000 g  for 60  min at 4°C.  The pilus pellet obtained 
was resuspended in 0.05  M  Tris,  pH  7.0, and the pH was adjusted until pilus 
aggregates were no longer visible by dark-field microscopy (pH 8.5). The solution 
was  centrifuged at  23,000  g  for 60  minutes at  4°C  and  the  supernatant  was 
adjusted to 45%  SAS.  Pilus aggregates were  again removed from solution by 
centrifugation at 8,000 g (60 min, 4°C), and the pellet was resuspended in 0.05 
M Tris, pH 8.5. Although yield and purity were not optimal with this preparation, 
the final purification product gave a  strongly staining Coomassie Blue protein 
band at 25,000  mol wt by SDS-PAGE,  and EM revealed intact pilus rods with 
little particulate contamination. This preparation was sufficiently pure to deter- 
mine optimal solution conditions for pilus solubilization and aggregation. 
Optimal  pilus  purification  conditions  were  determined  by  observing  pilus GUERINA  ET  AL.  149 
aggregation measured by solution optical density as a function of solvent pH and 
ionic strength (Figs.  1, 2). Maximal aggregation occurred at pH 5.0 or at an SAS 
concentration  of  ~45%  saturation  (ionic  strength,  5.5).  An  identical  ionic 
strength dependence was found with NaCI (data not shown). At low and moderate 
ionic strengths, pilus aggregates were completely dispersed at pH >9.0 and <3.0. 
Based on the solubility results,  the purification scheme shown in Fig.  3  was 
used for routine purification of H. influenzae  pili. The initial wash step followed 
by cycles of pH precipitation and solubilization coupled with differential centrif- 
ugation produced optimal yield and purity. However, several minor bands could 
be detected in most pilus preparations (Fig. 4a).  Two of these bands persisted, 
even with an added ammonium sulfate purification step. These bands also had 
molecular weights that corresponded closely to pi!us subunit multimers (49,000 
and 73,000). That these bands were in fact pilus subunit multimers was confirmed 
by immunoblotting on nitrocellulose paper using antiserum raised against the 
25,000 mol wt major band cut from an SDS-polyacrylamide gel. This antiserum 
completely coated intact pilus rods on the homologous A02 strain, as determined 
by  immunoelectron microscopy,  confirming that  the  major  SDS-PAGE  band 
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FIGURE  1.  The solubility of purified H. influenzae pili as a  function of pH at constant ionic 
strength (0.15).  Pili exist predominantly as single dispersed rods above pH 9.0 and below 3.0. 
Peak precipitation occurs at pH 5.0. 
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FIGURE  2.  The  solubility of purified H.  influenzae pili as a  function of percent saturated 
ammonium sulfate at constant pH (9.5). Peak pilus aggregation occurs at a percent saturation 
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I 
II 
III 
IV 
V 
VI 
Growth from 20-h culture harvested in 0.1  M Tris-HCI, pH 8.0 
8,000 g, 4°C, 20 min 
Pellet resuspended in 0.1 M Tris-HCl, pH 8.0 
Suspension blended (Sorvall Omnimixer ¾-maximal setting) 
8,000 g, 4°C, 20 min 
Supernatant  centrifuged, 23,000 g, 4°C, 60 min 
Vll 
VIll 
IX 
X 
XI 
XII 
XIII 
XIV 
Supernatant  dialyzed overnight against 0.01  M phosphate-buffered  saline, pH 5.0 
8,000 g, 4°C, 20 min 
Pellet resuspended in 0.05 M Tris-HCI, pH  10.5 
23,000 g, 4°C, 60 min 
Steps 7-10, repeated twice 
Supernatant  made 45% saturated ammonium sulfate 
8,000 g, 4°C, 60 min 
Pellet resuspended in final buffer 
FIGURE 3.  Purification  scheme proposed foi"  H. influenzae pili. 
contains pili (Fig. 5 c). By immunoblotting, the 49,000 and 73,000 mol wt minor 
bands  stained  with  an  antiserum  dilution  of  1:2000  (data  not  shown).  The 
intensities  of the  remaining  minor  bands  were  reduced,  but  not  completely 
eliminated, on Coomassie Blue-stained gels, by a single added 45% SAS extrac- 
tion (Fig. 4a). 
Although the pH is not optimal for separation of bacteria from detached pili 
in the initial blending/centrifugation  (steps 3-5), pilus preparations were found 
to contain lower quantities of protein impurities with the lower pH buffer (8.0). 
The initial buffer wash (steps  1 and 2) also decreased the amount of detectable 
protein  impurities.  Using  the  purification  procedure  outlined  in  Fig.  3,  most 
pilus preparations  showed  >90%  purity as estimated  by SDS-PAGE  (Fig.  4a); 
occasionally a pilus preparation  showed only a single 25;000  mol wt band (Fig. 
4a). 
Chemical and Physical Characterizatio~ of Purified H. influenzae Pili 
Subunit  molecular weight.  Fig.  4,  a  and  b,  shows  a  Coomassie  Blue-stained 
SDS-PAGE  profile  and  the  corresponding  log  molecular  weight  vs.  relative 
mobility graph of a highly purified preparation  of H. influenzae pili from strain 
A02.  A  single  band  is  observed  giving  an  apparent  subunit  (pilin)  molecular 
weight of 25,000.  Because  of its high purity, this preparation  was  used for all 
subsequent chemical and physical characterizations. 
Electron  microscopy.  Purified H.  influenzae  pili  consist  of thin  flexible  rods GUERINA  ET  AL.  151 
FIGURE 4.  SDS-PAGE of purified H.  influenzae  pili from strain A02. (a, left to right)  Pilus 
preparation showing only a  single Coomassie Blue-staining protein band; pilus preparation 
before saturated ammonium sulfate (SAS) extraction showing four minor bands in addition to 
the major protein band; pilus preparation after SAS extraction; SAS supernatant after removal 
by centrifugation of precipitated pili (Fig. 3, step 13); a portion of two of the minor protein 
contaminants (minor bands 3 and 4) can be seen in the discarded supernatant; a densitometer 
scan of the final pilus purification product (third gel lane from the left) indicating that ~90% 
of the protein detected is present in a single major band. (b) Log molecular weight vs. relative 
mobility plot. The major protein band has a molecular weight of 25,000, and minor protein 
bands 1 and 2 have molecular weights that correspond closely to multimers of the major band 
(49,000 and 73,000, respectively). 
when stained with uranyl acetate and examined by transmission EM (Fig.  5 b). 
Using tobacco  mosaic virus stacked double discs as  internal  size  markers,  the 
purified pili have a diameter of 4.5-6.0 nm. Their lengths vary from 0.4 to 1.5 
#m.  Purified E.  coli P  pili  have  similar  diameters  (5.0-7.0  nm)  with  lengths 
varying from 0.5 to 1.0 #m (26). 
Amino acid analysis  and sequence.  Purified H. influenzae pili were subjected to 
amino acid  analysis  and  the  results  compared  with  the  published amino  acid 
compositions of gonococcal pili (27) and  MS and  P E.  coli pili (20).  The most 
striking difference between H. influenzae pili and E. coli and gonococcal pili is in 
the number of cysteine residues. H.  influenzae pilin have four cysteine residues 
(Table  I),  whereas  E.  coli P  and  MS  pili  and  gonococcal  pili  each  have  two 
cysteine residues per subunit, and these exist in a disulfide bond. This difference 
may be significant in terms of the tertiary structures of the pilus subunits. 152  CHARACTERIZATION  OF  PURIFIED H.  INFLUENZAE  PILI 
FIGURE 5.  EM of piliated H. influenzae and purified pili. (a) The piliated phase of strain A02. 
×  30,000. (b) Purified A02 pili with tobacco mosaic virus (TMV) stacked double discs (arrow) 
as an internal size standard.  The disc center-to-center repeating distance along the long axis 
is 4.5  nm.  The pilus diameter  measures  4.5-6.0  nm.  (c)  Immunolabeling of A02 pili with 
antiserum raised against the major (25,000  tool wt) protein band cut from an electrophoresis 
gel. The pill appear thickened and fuzzy (compared with a), and multiple pili are cross-linked 
into large aggregates extending from the cell surface.  Antiserum dilution,  1:500.  x  18,000. 
(d)  Immunolabeling of A03 pill with antiserum  raised against purified E.coli HU849 P  pili. 
Complete coating of pilus rods with antibody  is seen as described in c. Antiserum dilution, 
1:40. x  18,000. 
The amino-terminal amino acid sequence of H. influenzae pili was determined 
through residue  40 (Table  II) and compared with the sequences of E.  coli  MS 
and  P  pili  (20)  and  gonococcal  pili  (27).  When  the  cysteine  residues  of H. 
influenzae and E.  coli MS and P pili are aligned,  11  (27.5%) and 10 (25%) of the 
first  40  residues  of  P  and  MS  pili,  respectively,  are  homologous  with  the 
Haemophilus  pilus sequence.  This is comparable to the number of homologous 
residues between  P  and  MS E.  coli pili  (12  of 40,  or  30%)  in  this region, but 
substantially different than the number of homologous residues between gono- 
coccal and Haemophilus pili (3 of 40, 7.5%). 
Serological  Analysis of H.  influenzae Pili.  Subcutaneous injections with highly 
purified A02 pili produced a high titer homologous antiserum in rabbits (average 
titer,  400,000)  as  determined  by  ELISA.  Using  this  antiserum,  studies  on 
heterologous cross-reactivity  were  initiated  with  purified  pili  from  three  ran- 
domly selected clinical isolates of H.  influenzae (Table III). Pili from one of the 
strains (A46) showed very ,high serological cross-reactivity.  The remaining two 
strains showed significant cross-reactivity with heterologous titers of 12 and 16% 
of the  homologous A02  titer.  Similar  results  were  obtained  using  antiserum GUERINA  ET  AL.  153 
TABLE  I 
Amino Acid Composition of H. influenzae,  E. coli Type I  and P, and 
N. gonorrhoeae 
Integral number: residues per subunit* 
Amino acid  E. coli  N. 
H. influenzae  E. coli P*  type I  s  gonorrhoeae* 
Ala  20  17  35  18 
Val  21  17  14  15 
Leu  15  9  14  11 
Ile  9  6  5  9 
Pro  8  5  2  6 
Phe  10  7  8  1 
Trp  ND  0  ND  ND  3 
Met u  3  1  ND  2 
Asx  41  19  18  17 
Glx  25  13  16  14 
Lys  21  10  4  15 
Arg  2  ND  2  5 
His  6  2  2  2 
Gly  17  21  21  11 
Ser  6  11  9  11 
Thr  20  12  20  11 
V2 Cys  I  4  2  2  2 
Tyr  8  2  2  5 
* Based on molecular weights of 25,000 (H. influenzae pili), 17,500 (P and 
N. gonorrhoeae), and  18,000  (type  I  pili) estimated  by SDS-PAGE or 
calculated from the sequence (19, 28). 
* Literature citations reporting the indicated amino acid compositions are 
as follows: P (28); type I (20); N. gonorrhoeae (27). 
! No amino acid was detected. 
I For HI and type I pili, cysteine was analyzed as cysteic acid and methi- 
onine as methionine sulfone after performic acid oxidation (23).  For P 
and N. gonorrhoeae, cysteine and metbionine were calculated from  the 
amino acid sequence. 
produced against the major A02 pilus protein band cut from an SDS-polyacryl- 
amide gel (data not shown). Thus, it is unlikely that cross-reactivity resulted from 
antibodies  produced  against  nondetectable  contaminating  nonpilus  antigens 
which might be present in purified pilus preparations.  No activity was detected 
in rabbit preimmune serum. 
No  serological  cross-reactivity  was  detected  between  the  mannose-sensitive 
(MS) pili from E.  coli H10407  and C94, and the H. influenzae pili tested (Table 
III).  However,  low  reproducible  titers  were  observed  when  antisera  against 
purified E.  coli P pili was tested against purified A02 and A46 pili (Table  III). 
Similarly, low cross-reactivity  was detected between purified E.  coli  HU849  pili 
and A02  antisera  (including antiserum produced  against the major pilus band 
cut from  an  SDS-polyacrylamide  gel).  No activity  was  detected  in preimmune 
sera corresponding to all the antisera tested. 
The serological relatedness between A02 pili and the pili from four additional 
randomly  selected  H.  influenzae  strains  (including  one  nontypable  strain)  was 
examined by  whole  piliated  bacterial  cell agglutination  (Table  IV).  This  tech- T
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TABLE Ill 
influenzae  (HI) and E. coli (EC) Pilus Antisera by ELISA 
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Pili 
Antiserum 
A02 (HI)  HU849 P (EC) 3669 P (EC)  H10407 MS (EC)  C94 MS (EC) 
A02 (HI)  400,000  4,000  2,000  <200  <200 
A 14 (HI)  64,000  ND  ND  <200  <200 
A 16 (HI)  48,500  ND  ND  <200  <200 
A46 (HI)  400,000  2,000  2,000  <200  <200 
HU849 P (EC)  3,000  128,000  ND  <200  <200 
H10407 MS (EC)  <200  <200  ND  256,000  8,000 
C94 MS (EC)  <200  <200  ND  4,000  256,000 
TABLE IV 
Log-normal titers for H. influenzae  (HI) and E. coli (EC) pilus antisera by whole piliated cell 
agglutination 
Antiserum 
Pill 
A02 (HI)  HU849 P (EC) 3669 P(EC)  H10407 MS (EC)  C94 MS (EC) 
A01 (HI)  1,500  <10  <10  <10  <10 
A02 (HI)  64,000  2,000  2,000  <10  <10 
A03 (HI)  2,000  8,000  2,000  <10  <10 
AI4 (HI)  8,000  1,000  1,000  <I0  <10 
A16 (HI)  11,000  <200  <200  <10  <10 
A43 (HI)  6,000  <10  <10  <10  <10 
A46 (HI)  64,000  2,000  2,000  <10  <10 
A52 (HI)  64,000  2,000  1,000  <10  <10 
J96 P (EC)*  2,000  32,000  <50  <10  <10 
3669 P (EC)  1,000  <50  32,000  <10  <I0 
H10407 MS (EC)  <10  <10  <10  64,000  <50 
C94 MS (EC)  <10  <10  <10  <50  64,000 
* J96 is the parent strain used for production  of HU849 recombinant strain. 
nique detected serological relatedness identical to that obtained by ELISA when 
strains A 14, A 16, and A46 were tested. Of the additional strains tested, the pili 
from one (A52) showed very high serological relatedness with A02 pili. Thus, of 
a  total of eight H.  influenzae  strains examined,  three  (A02,  A46,  A52)  showed 
very high serological relatedness. The remaining strains all showed some degree 
of serological  relatedness  with  cross-reactivities  ranging  from  2  to  17%.  No 
activity was detected  with  nonpiliated  isogenic  variants  (controls)  obtained  for 
seven of the eight strains examined. No activity was detected in preimmune sera 
corresponding to the  A02 antisera tested.  Identical serological relatedness was 
detected using antiserum produced against highly purified A02 pili, or the major 
A02 pilus band cut from an SDS-polyacrylamide gel. 
Whole  piliated  cell  agglutination  with  antisera  against  purified E.  coli  P  pili 
showed cross-reactivity with five of the eight H.  influenzae  strains tested (Table 
IV).  In  each  case  no activity was  detected  with  preimmune  control  sera.  The 
highest titer was seen between the nontypable strain  A03 and E.  coli  HU849  P 
pilus antiserum.  Strain  A03 is stably piliated, so an isogenic nonpiliated  variant 
was  not  available  to  help  control  for  the  possible  presence  of cross-reactive 156  CHARACTERIZATION  OF  PURIFIED H.  INFLUENZAE  PILl 
antibodies  against  nonpilus  cell  surface  antigens.  However,  no  agglutinating 
activity was detected with the nonpiliated variants of the other seven H. influenzae 
strains.  Furthermore,  immunoelectron microscopy clearly  demonstrated com- 
plete  coating  of A03  pili  by  E.  coli  HU849  P  pilus antiserum  (Fig.  5d).  No 
serological relatedness was observed between E.  coli  MS pili and H.  influenzae 
pili. 
Discussion 
Haemophilus  influenzae  pili  were  purified and  found  to  consist of multiple 
copies of a single protein subunit having an apparent molecular weight of 25,000. 
The  purification  procedure  involves  simple  manipulations  of  solvent  ionic 
strength and pH coupled with differential centrifugation. Pilus preparations of 
>90% estimated protein purity were obtained with some preparations having no 
detectable contaminating protein bands. Purified pili consisted of intact rods that 
measured 4.5-6.0 nm diam and had variable lengths of 0.4-1~5 #m. 
The  amino  acid  compositions and  N-terminal  amino acid  sequences of H. 
influenzae pili, E.  coli MS, and P pili and gonococcal pili were compared in this 
study (Tables I, II). A remarkable segment of conserved sequence was found for 
H. influenzae pili and E. coli P pili between positions 8 and 20, where 9 of the 14 
residues (64%) are identical.  Indeed, the pattern of sequence homology previ- 
ously recognized between E. coli P and MS pili (19) in this region (-GIy-X - Val- 
X  -Phe-X -GIy-X -Val-Val-Asx-Ala-Xs-Cys-,  where the intervening residues (X) 
tend to be charged or polar uncharged) is also evident between H. influenzae pili 
and the two E. coli pilus proteins. 
These considerations suggest that these pili may be descendents of a common 
ancestral gene. The shared antigenicity between P  pili and some H.  influenzae 
pili support this proposal and might indicate that these two pilus proteins diverged 
more recently and are therefore more generally homologous than either are to 
MS pili. However, the presence of four cysteine residues per H. influenzae subunit 
(Table  I) and two per E.  coli  MS and  P  pilus subunit suggests that significant 
differences in primary structure may occur beyond the area of known sequence, 
or that the region of the H. influenzae gene encoding a disulfide loop may have 
been duplicated. 
Purified A02 pili were found to be highly antigenic, and varying degrees of 
serological relatedness were found between purified A02 pili and the purified 
pili from the three heterologous H.  influenzae type b  strains tested (Table III). 
Cross-reactivity was also found when A02 pilus antiserum was tested against six 
additiOnal heterologous type b  strains and one nontypable H.  influenzae isolate 
by whole piliated cell agglutination (Table IV). Thus, it seems likely that some 
degree of cross-reactivity will be found among the pili from many H. influenzae 
strains. Also, there may be a  limited number of major antigenic groups among 
H. influenzae pili, since three strains (A02, A46, A52) were found to have very 
high serological  identity  in  this  limited  study.  This  is  in  striking  contrast  to 
gonococcal pili,  for  which no  serological  identity has  been  found among the 
major antigenic determinants of pili from heterologous strains (10, 21). 
Significant cross-reactivity was found between H.  influenzae pili and E. coli P 
pili.  This correlates  with the high degree of sequence homology between  the GUERINA  ET  AL.  157 
pili;  however, more extensive serological analysis will need to be carried out to 
determine if H. influenzae and E. coli P pili belong to the same antigenic family, 
or if there is some divergence of the major antigenic determinants. 
The proposed purification scheme (Fig.  1) is rapid and simple, using inexpen- 
sive reagents. It yields pilus preparations of sufficient purity for many physical 
and chemical characterization studies.  Furthermore, preparations are likely to 
be adequate for accurate serological analysis since identical serological results 
were obtained either with antiserum produced against a complete purified pilus 
suspension or antiserum produced against the major pilus protein band cut from 
an SDS-polyacrylamide gel. Using this purification procedure, a more extensive 
serological analysis of pili from many clinical isolates of 14. influenzae is currently 
underway. 
Summary 
Haemophilus  influenzae  pili  were purified, and their physical and serological 
properties were examined. The solution properties of the pili were determined, 
and then a  purification scheme involving repeated cycles of precipitation and 
solubilization  was developed. The purified pili  from one type b  isolate (A02) 
were found to consist of multiple copies of a  25,000  mol wt subunit.  Amino- 
terminal sequence analysis of A02 pili was carried out to 40 amino acid residues, 
and a  remarkable degree of sequence homology was found with E.  coil P  and 
mannose-sensitive (MS) pili (27.5 and 25% homology, respectively). Purified A02 
pili were found to be highly immunogenic, and serological analysis by enzyme- 
linked immunosorbent assay and whole piliated cell agglutination revealed sig- 
nificant cross-reactivity between A02 pilus antiserum and the pili of seven other 
H.  influenzae  strains tested (heterologous titers =  2-100%  of the homologous 
titer). Cross-reactivity was also observed between the H.  infleunzae pili (five of 
eight strains tested) and the P pili from E. coli strains HU849 and 3669; no cross- 
reactivity was detected with MS pili from E.  coli strain H10407  and C94.  The 
structural similarities between H.  influenzae and E. coli P and MS pili sfiggest a 
common gene ancestry. 
Received for publication 20 September 1984. 
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